More on AGRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.60 |
|
|||
| Open | $0.60 | ||||
| 52 Wk High | $10.41 | ||||
| 52 Wk Low | $5.32 | ||||
| Day High | $0.60 | ||||
| Day Low | $0.60 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,396 | ||||
- Form 8-K AGILE THERAPEUTICS INC For: Apr 09
- Form 10-K AGILE THERAPEUTICS INC For: Dec 31
- Form 8-K AGILE THERAPEUTICS INC For: Mar 28
- Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
- Form 8-K AGILE THERAPEUTICS INC For: Mar 22
- Agile Therapeutics (AGRX) Announces Delisting
- Agile Therapeutics Announces Delisting from Nasdaq
- Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
- Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
- Maxim Group Downgrades Agile Therapeutics (AGRX) to Hold
Entities mentioned with AGRX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- AdCom | View Related Stories »
- H.C. Wainwright | View Related Stories »
- S3 | View Related Stories »
- RBC Capital | View Related Stories »
- Show More...
